Clinical trial
Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With…
NCT00260533 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT00260533 |
|---|---|
| Title | Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder |
| Official title | Double Blind Placebo Controlled Parallel Group Comparison of Atomoxetine (Strattera) for Generalized Social Anxiety Disorder (GSAD) |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Generalized Social Phobia |
| Intervention type | Drug |
| Interventions | atomoxetine, placebo |
| Enrollment | 27 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Dec 1, 2005 |
| Last update posted | Jun 24, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: